“Perioperative immune checkpoint inhibitors plus chemotherapy versus chemotherapy alone in resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis” (2026) Nepal Journal of Epidemiology, 16(1), pp. 1412–1423. doi:10.3126/nje.v16i1.92321.